Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...

Additional drug combinations may carry a risk of more side effects though, raising concerns from some doctors. Regeneron ...

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

From today, June 23, GPs can prescribe Mounjaro, a weight loss injection, to certain patients on the NHS. The drug, also ...

And promoting these drugs, in the absence of a comprehensive plan to tackle the underlying causes of obesity, will not ...

Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with ...

Prescriptions for Mounjaro jabs, an effective weight loss pill, are now accessible at general practitioners' surgeries in ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...